[New aspects in the treatment of oxalate lithiasis (author's transl)].
The causes of hypercalciuria and simple diagnostic criteria for the various forms of hypercalciuria are outlined. Indications, effectiveness, limitations, and side effects of cellulose phosphate are described. Emphasis is placed on the biochemical pathogenesis and classification of hyperoxaluria. The problems of measuring and controlling oxalate excretion in patients with hyperoxaluria and calcium oxalate stones are discussed. Succinimide offers a partly successful approach to the reduction of endogenous oxalate synthesis.
D002118:Calcium / Q000378:metabolism / Q000652:urine*; D002128:Calcium Metabolism Disorders / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D002482:Cellulose / Q000627:therapeutic use*; D006038:Glyoxylates / Q000378:metabolism; D006801:Humans; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010070:Oxalates / Q000378:metabolism / Q000652:urine*; D010710:Phosphates / Q000009:adverse effects; D013388:Succinimides / Q000009:adverse effects / Q000627:therapeutic use*; D014545:Urinary Calculi / Q000188:drug therapy* / Q000209:etiology
D006038:Glyoxylates; D009943:Organophosphorus Compounds; D010070:Oxalates; D010710:Phosphates; D013388:Succinimides; D002482:Cellulose; D002118:Calcium
Neue Gesichtspunkte in der Behandlung des Oxalatsteinleidens